Cutler Group’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,500
Closed -$11K 851
2023
Q4
$11K Hold
4,500
﹤0.01% 966
2023
Q3
$9K Hold
4,500
﹤0.01% 1036
2023
Q2
$10K Hold
4,500
﹤0.01% 972
2023
Q1
$13K Hold
4,500
﹤0.01% 936
2022
Q4
$10K Sell
4,500
-252
-5% -$560 ﹤0.01% 1267
2022
Q3
$9K Sell
4,752
-406
-8% -$769 ﹤0.01% 1382
2022
Q2
$13K Sell
5,158
-42
-0.8% -$106 ﹤0.01% 1301
2022
Q1
$15K Sell
5,200
-18,504
-78% -$53.4K ﹤0.01% 1432
2021
Q4
$92K Buy
23,704
+17,504
+282% +$67.9K ﹤0.01% 958
2021
Q3
$26K Buy
6,200
+1,000
+19% +$4.19K ﹤0.01% 1445
2021
Q2
$15K Hold
5,200
﹤0.01% 1609
2021
Q1
$17K Hold
5,200
﹤0.01% 1497
2020
Q4
$18K Hold
5,200
﹤0.01% 1305
2020
Q3
$16K Buy
+5,200
New +$16K ﹤0.01% 1193
2019
Q2
Sell
-3,600
Closed -$12K 1515
2019
Q1
$12K Buy
3,600
+3,000
+500% +$10K ﹤0.01% 1158
2018
Q4
$2K Buy
+600
New +$2K ﹤0.01% 1455
2018
Q3
Sell
-500
Closed -$3K 1566
2018
Q2
$3K Hold
500
﹤0.01% 1495
2018
Q1
$2K Sell
500
-3,200
-86% -$12.8K ﹤0.01% 1653
2017
Q4
$18K Buy
3,700
+2,300
+164% +$11.2K ﹤0.01% 1422
2017
Q3
$8K Sell
1,400
-400
-22% -$2.29K ﹤0.01% 1960
2017
Q2
$6K Sell
1,800
-26,951
-94% -$89.8K ﹤0.01% 2322
2017
Q1
$93K Buy
28,751
+17,287
+151% +$55.9K ﹤0.01% 1182
2016
Q4
$28K Buy
11,464
+1,784
+18% +$4.36K ﹤0.01% 1763
2016
Q3
$33K Sell
9,680
-1,100
-10% -$3.75K ﹤0.01% 1615
2016
Q2
$37K Sell
10,780
-1,300
-11% -$4.46K ﹤0.01% 1511
2016
Q1
$49K Buy
12,080
+7,500
+164% +$30.4K ﹤0.01% 1305
2015
Q4
$20K Buy
+4,580
New +$20K ﹤0.01% 1856